CRNX Market Cap History



Below is a table of the CRNX market cap history going back to 7/18/2018:

Date CRNX Market Cap
7/18/2018539.42M
8/24/2018786.55M
10/31/2018598.76M
2/28/2019575.88M
4/30/2019626.39M
7/31/2019490.78M
10/31/2019426.55M
2/28/2020505.59M
4/30/2020547.86M
7/31/2020456.42M
10/31/2020397.70M
2/26/2021505.01M
4/30/2021650.74M
7/31/2021693.37M
10/31/20211.18B
3/25/202210.24B
5/9/2022882.31M
8/9/20221.14B
11/9/2022905.09M
2/24/20231.06B
5/5/20231.21B
8/31/2023947.17M
10/31/20231.96B
2/20/20242.60B
5/6/20243.67B
8/5/20243.93B
11/8/20245.63B

Also see: CRNX Shares Outstanding History
and CRNX YTD Return
CRNX Historical Market Cap:
+44.97% CAGR
CRNX Historical Market Cap: +44.97% CAGR

Mouse over chart for data details
7/18/2018 ...11/8/2024
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. We show 27 historical shares outstanding datapoints in our CRNX shares outstanding history coverage, used to compute CRNX market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CRNX market cap history over the course of time is important for investors interested in comparing CRNX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CRNX versus a peer is one thing; comparing CRNX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CRNX can fluctuate over the course of history. With this page we aim to empower investors researching CRNX by allowing them to research the CRNX market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree CRNX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Crinetics Pharmaceuticals (CRNX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

CRTX Market Cap History
CRVL Market Cap History
CRVO Market Cap History
CRVS Market Cap History
CRY Market Cap History
CSBR Market Cap History
CSII Market Cap History
CSTL Market Cap History
CSU Market Cap History
CTIC Market Cap History
More Healthcare companies »

 

CRNX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.